Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions

被引:53
|
作者
Ellerbrock, TV [1 ]
Lennox, JL
Clancy, KA
Schinazi, RF
Wright, TC
Pratt-Palmore, M
Evans-Strickfaden, T
Schnell, C
Pai, R
Conley, LJ
Parrish-Kohler, EE
Bush, TJ
Tatti, K
Hart, CE
机构
[1] CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[2] CDCP, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[3] Emory Univ, Sch Med, Dept Med, Grady Infect Dis Program, Atlanta, GA USA
[4] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[5] Vet Affairs Med Ctr, Georgia Vet Affairs Res AIDS & HIV Infect, Atlanta, GA USA
[6] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2001年 / 184卷 / 01期
关键词
D O I
10.1086/321000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most human immunodeficiency virus type 1 (HIV-1) transmission worldwide is the result of exposure to infectious virus in genital secretions. However, current vaccine candidates are based on virus isolates from blood. In this study, vaginal secretions from HIV-1-infected women were examined for evidence of cellular viral replication that produced virus with properties different from that in blood. Multiply spliced HIV-1 messenger RNA, which is found only in cells replicating virus, was detected in all vaginal lavage samples tested. There was a strong correlation between the amounts of multiply spliced HIV-1 messenger RNA and of cell-free HIV-1 RNA in the lavage samples. In addition, significant genotypic differences were found in cell-free virus from matched blood plasma and vaginal secretions. Moreover, drug resistance-associated mutations appeared in plasma virus several months before appearing in vaginal virus. These findings indicate that cellular replication of HIV-1 occurs in vaginal secretions and can result in a virus population with important differences from that in blood.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 50 条
  • [21] Replication of human immunodeficiency virus type 1 from entry to exit
    Andrew M. L. Lever
    Kuan-Teh Jeang
    International Journal of Hematology, 2006, 84 : 23 - 30
  • [22] The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication
    Roy, J
    Paquette, JS
    Fortin, JF
    Tremblay, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3447 - 3455
  • [23] Role of Cellular RNA Processing Factors in Human Immunodeficiency Virus Type 1 mRNA Metabolism, Replication, and Infectivity
    Jablonski, Joseph A.
    Caputi, Massimo
    JOURNAL OF VIROLOGY, 2009, 83 (02) : 981 - 992
  • [24] RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication
    Surabhi, RM
    Gaynor, RB
    JOURNAL OF VIROLOGY, 2002, 76 (24) : 12963 - 12973
  • [25] Herpes simplex virus infection induces replication of human immunodeficiency virus type 1
    Moriuchi, M
    Moriuchi, H
    Williams, R
    Straus, SE
    VIROLOGY, 2000, 278 (02) : 534 - 540
  • [26] Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression
    Naif, HM
    Chang, J
    HoShon, M
    Li, S
    Cunningham, AL
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (13) : 1237 - 1245
  • [27] CELLULAR ANTIOXIDANT STATUS AND HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION
    BAKER, DH
    WOOD, RJ
    NUTRITION REVIEWS, 1992, 50 (01) : 15 - 18
  • [28] Potentiation of human immunodeficiency virus type 1 Tat by human cellular proteins
    Greenberg, ME
    Ostapenko, DA
    Mathews, MB
    JOURNAL OF VIROLOGY, 1997, 71 (09) : 7140 - 7144
  • [29] The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1
    Wang, CC
    McClelland, RS
    Reilly, M
    Overbaugh, J
    Emery, SR
    Mandaliya, K
    Chohan, B
    Ndinya-Achola, J
    Bwayo, J
    Kreiss, JK
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07): : 1017 - 1022
  • [30] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480